Form 4 Tracker
Immunome Inc.
IMNM

10 insider filings · Latest: Jul 23, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 5, 2026Jun 9 9:40 PMJean Jacques BienaimeDirector
Purchase
10,500$19.45$204.3K43,415(D)

View →

Jun 5, 2026Jun 9 9:40 PMJean Jacques BienaimeDirector
Sale
10,500$19.41$203.8K32,915(D)

View →

May 15, 2026May 19 11:56 AMJean Jacques BienaimeDirector
Purchase
5,000$20.70$103.5K43,415(D)

View →

Mar 11, 2026Mar 12 10:05 AMJean Jacques BienaimeDirector
Purchase
1,000$21.55$21.6K38,415(D)

View →

Mar 10, 2026Mar 12 10:05 AMJean Jacques BienaimeDirector
Purchase
1,000$22.12$22.1K37,415(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 23, 2026Jul 27 8:10 PMKinney HornCHIEF BUSINESS OFFICER
Grant/Award
62,500$22.0162,500(D)

View →

Jul 23, 2026Jul 27 8:10 PMPhilip TsaiChief Technical Officer
Grant/Award
76,500$22.0176,500(D)

View →

Jul 23, 2026Jul 27 8:10 PMSandra G. StonemanCHIEF LEGAL OFFICER & GC
Grant/Award
76,500$22.0176,500(D)

View →

Jul 23, 2026Jul 27 8:10 PMJack HigginsChief Scientific Officer
Grant/Award
76,500$22.0176,500(D)

View →

Jul 23, 2026Jul 27 8:10 PMMax RosettChief Financial Officer
Grant/Award
94,500$22.0194,500(D)

View →

Jul 23, 2026Jul 27 8:10 PMRobert LechleiderChief Medical Officer
Grant/Award
108,000$22.01108,000(D)

View →

Jul 23, 2026Jul 27 8:10 PMClay B SiegallDirector, President and CEO
Grant/Award
360,000$22.01360,000(D)

View →